nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—PTGS2—type 2 diabetes mellitus	0.138	0.529	CbGaD
Diflunisal—ALB—type 2 diabetes mellitus	0.123	0.471	CbGaD
Diflunisal—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0404	0.0841	CbGbCtD
Diflunisal—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0404	0.0841	CbGbCtD
Diflunisal—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0373	0.0776	CbGbCtD
Diflunisal—ALB—Gliclazide—type 2 diabetes mellitus	0.0355	0.0739	CbGbCtD
Diflunisal—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0355	0.0738	CbGbCtD
Diflunisal—ALB—Repaglinide—type 2 diabetes mellitus	0.0334	0.0695	CbGbCtD
Diflunisal—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0316	0.0657	CbGbCtD
Diflunisal—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0306	0.0637	CbGbCtD
Diflunisal—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0294	0.0611	CbGbCtD
Diflunisal—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0279	0.058	CbGbCtD
Diflunisal—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0269	0.0559	CbGbCtD
Diflunisal—ALB—Valsartan—type 2 diabetes mellitus	0.0246	0.0512	CbGbCtD
Diflunisal—ALB—Nateglinide—type 2 diabetes mellitus	0.0229	0.0476	CbGbCtD
Diflunisal—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0182	0.0378	CbGbCtD
Diflunisal—SLC22A6—Losartan—type 2 diabetes mellitus	0.0166	0.0345	CbGbCtD
Diflunisal—ALB—Glyburide—type 2 diabetes mellitus	0.0155	0.0322	CbGbCtD
Diflunisal—ALB—Losartan—type 2 diabetes mellitus	0.0141	0.0294	CbGbCtD
Diflunisal—TTR—peripheral nervous system—type 2 diabetes mellitus	0.00364	0.14	CbGeAlD
Diflunisal—UGT1A8—kidney—type 2 diabetes mellitus	0.00212	0.0817	CbGeAlD
Diflunisal—PTGS2—leg—type 2 diabetes mellitus	0.00181	0.07	CbGeAlD
Diflunisal—PTGS2—hindlimb—type 2 diabetes mellitus	0.00162	0.0626	CbGeAlD
Diflunisal—TTR—islet of Langerhans—type 2 diabetes mellitus	0.00137	0.053	CbGeAlD
Diflunisal—UGT1A8—liver—type 2 diabetes mellitus	0.00134	0.0516	CbGeAlD
Diflunisal—TTR—retina—type 2 diabetes mellitus	0.00117	0.0453	CbGeAlD
Diflunisal—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.00113	0.0437	CbGeAlD
Diflunisal—PTGS1—artery—type 2 diabetes mellitus	0.00104	0.0401	CbGeAlD
Diflunisal—PTGS2—artery—type 2 diabetes mellitus	0.000993	0.0383	CbGeAlD
Diflunisal—TTR—cardiovascular system—type 2 diabetes mellitus	0.000993	0.0383	CbGeAlD
Diflunisal—TTR—kidney—type 2 diabetes mellitus	0.000972	0.0375	CbGeAlD
Diflunisal—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.000969	0.0374	CbGeAlD
Diflunisal—TTR—pancreas—type 2 diabetes mellitus	0.000965	0.0373	CbGeAlD
Diflunisal—PTGS1—endothelium—type 2 diabetes mellitus	0.000878	0.0339	CbGeAlD
Diflunisal—PTGS2—endothelium—type 2 diabetes mellitus	0.000839	0.0324	CbGeAlD
Diflunisal—TTR—liver—type 2 diabetes mellitus	0.000614	0.0237	CbGeAlD
Diflunisal—Olsalazine—PPARG—type 2 diabetes mellitus	0.000552	0.203	CrCbGaD
Diflunisal—Niclosamide—CYP1A2—type 2 diabetes mellitus	0.00051	0.187	CrCbGaD
Diflunisal—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000477	0.0184	CbGeAlD
Diflunisal—Mesalazine—PPARG—type 2 diabetes mellitus	0.000407	0.149	CrCbGaD
Diflunisal—ALB—liver—type 2 diabetes mellitus	0.000392	0.0151	CbGeAlD
Diflunisal—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000361	0.0139	CbGeAlD
Diflunisal—PTGS1—kidney—type 2 diabetes mellitus	0.000353	0.0136	CbGeAlD
Diflunisal—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000345	0.0133	CbGeAlD
Diflunisal—PTGS2—kidney—type 2 diabetes mellitus	0.000338	0.013	CbGeAlD
Diflunisal—PTGS2—pancreas—type 2 diabetes mellitus	0.000336	0.013	CbGeAlD
Diflunisal—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000319	0.0123	CbGeAlD
Diflunisal—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000304	0.0118	CbGeAlD
Diflunisal—Olsalazine—PTGS2—type 2 diabetes mellitus	0.000233	0.0855	CrCbGaD
Diflunisal—Aminosalicylic Acid—PTGS2—type 2 diabetes mellitus	0.000219	0.0804	CrCbGaD
Diflunisal—PTGS2—liver—type 2 diabetes mellitus	0.000214	0.00824	CbGeAlD
Diflunisal—Salsalate—PTGS2—type 2 diabetes mellitus	0.000198	0.0727	CrCbGaD
Diflunisal—Mesalazine—PTGS2—type 2 diabetes mellitus	0.000172	0.0631	CrCbGaD
Diflunisal—Syncope—Metformin—type 2 diabetes mellitus	0.00014	0.000961	CcSEcCtD
Diflunisal—Oedema—Valsartan—type 2 diabetes mellitus	0.00014	0.00096	CcSEcCtD
Diflunisal—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00014	0.00096	CcSEcCtD
Diflunisal—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00014	0.000959	CcSEcCtD
Diflunisal—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00014	0.000958	CcSEcCtD
Diflunisal—Rash—Glipizide—type 2 diabetes mellitus	0.000139	0.000953	CcSEcCtD
Diflunisal—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000139	0.000953	CcSEcCtD
Diflunisal—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000139	0.000952	CcSEcCtD
Diflunisal—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000139	0.000951	CcSEcCtD
Diflunisal—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000138	0.000949	CcSEcCtD
Diflunisal—Oedema—Orlistat—type 2 diabetes mellitus	0.000138	0.000949	CcSEcCtD
Diflunisal—Headache—Glipizide—type 2 diabetes mellitus	0.000138	0.000947	CcSEcCtD
Diflunisal—Palpitations—Metformin—type 2 diabetes mellitus	0.000138	0.000947	CcSEcCtD
Diflunisal—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000138	0.000945	CcSEcCtD
Diflunisal—Shock—Valsartan—type 2 diabetes mellitus	0.000138	0.000944	CcSEcCtD
Diflunisal—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000137	0.000941	CcSEcCtD
Diflunisal—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000137	0.00094	CcSEcCtD
Diflunisal—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000137	0.000938	CcSEcCtD
Diflunisal—Flatulence—Losartan—type 2 diabetes mellitus	0.000137	0.000937	CcSEcCtD
Diflunisal—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000137	0.000937	CcSEcCtD
Diflunisal—Tension—Losartan—type 2 diabetes mellitus	0.000136	0.000933	CcSEcCtD
Diflunisal—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000136	0.000933	CcSEcCtD
Diflunisal—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000136	0.000932	CcSEcCtD
Diflunisal—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000136	0.00093	CcSEcCtD
Diflunisal—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000136	0.000929	CcSEcCtD
Diflunisal—Urticaria—Glyburide—type 2 diabetes mellitus	0.000135	0.000924	CcSEcCtD
Diflunisal—Nervousness—Losartan—type 2 diabetes mellitus	0.000135	0.000924	CcSEcCtD
Diflunisal—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000135	0.000924	CcSEcCtD
Diflunisal—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000134	0.00092	CcSEcCtD
Diflunisal—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000134	0.000917	CcSEcCtD
Diflunisal—Anorexia—Valsartan—type 2 diabetes mellitus	0.000134	0.000915	CcSEcCtD
Diflunisal—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000133	0.000915	CcSEcCtD
Diflunisal—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000133	0.000913	CcSEcCtD
Diflunisal—Chest pain—Metformin—type 2 diabetes mellitus	0.000133	0.000912	CcSEcCtD
Diflunisal—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000132	0.000908	CcSEcCtD
Diflunisal—Headache—Pioglitazone—type 2 diabetes mellitus	0.000132	0.000907	CcSEcCtD
Diflunisal—Syncope—Irbesartan—type 2 diabetes mellitus	0.000132	0.000906	CcSEcCtD
Diflunisal—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000132	0.000903	CcSEcCtD
Diflunisal—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000131	0.000901	CcSEcCtD
Diflunisal—Nausea—Glipizide—type 2 diabetes mellitus	0.000131	0.000898	CcSEcCtD
Diflunisal—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000131	0.000897	CcSEcCtD
Diflunisal—Vision blurred—Losartan—type 2 diabetes mellitus	0.000131	0.000897	CcSEcCtD
Diflunisal—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00013	0.000894	CcSEcCtD
Diflunisal—Constipation—Gliclazide—type 2 diabetes mellitus	0.00013	0.000893	CcSEcCtD
Diflunisal—Rash—Glimepiride—type 2 diabetes mellitus	0.00013	0.00089	CcSEcCtD
Diflunisal—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00013	0.000889	CcSEcCtD
Diflunisal—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.00013	0.000888	CcSEcCtD
Diflunisal—Rash—Sitagliptin—type 2 diabetes mellitus	0.000129	0.000887	CcSEcCtD
Diflunisal—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000129	0.000886	CcSEcCtD
Diflunisal—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000129	0.000886	CcSEcCtD
Diflunisal—Headache—Glimepiride—type 2 diabetes mellitus	0.000129	0.000884	CcSEcCtD
Diflunisal—Headache—Sitagliptin—type 2 diabetes mellitus	0.000129	0.000881	CcSEcCtD
Diflunisal—Oedema—Metformin—type 2 diabetes mellitus	0.000128	0.000874	CcSEcCtD
Diflunisal—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000127	0.000874	CcSEcCtD
Diflunisal—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000127	0.000871	CcSEcCtD
Diflunisal—Flushing—Ramipril—type 2 diabetes mellitus	0.000127	0.00087	CcSEcCtD
Diflunisal—Angioedema—Losartan—type 2 diabetes mellitus	0.000127	0.000869	CcSEcCtD
Diflunisal—Insomnia—Valsartan—type 2 diabetes mellitus	0.000127	0.000868	CcSEcCtD
Diflunisal—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000126	0.000862	CcSEcCtD
Diflunisal—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000126	0.000861	CcSEcCtD
Diflunisal—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000126	0.000861	CcSEcCtD
Diflunisal—Shock—Metformin—type 2 diabetes mellitus	0.000125	0.00086	CcSEcCtD
Diflunisal—Insomnia—Orlistat—type 2 diabetes mellitus	0.000125	0.000858	CcSEcCtD
Diflunisal—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000125	0.000857	CcSEcCtD
Diflunisal—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000125	0.000856	CcSEcCtD
Diflunisal—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000125	0.000856	CcSEcCtD
Diflunisal—Vertigo—Losartan—type 2 diabetes mellitus	0.000125	0.000855	CcSEcCtD
Diflunisal—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000125	0.000854	CcSEcCtD
Diflunisal—Somnolence—Valsartan—type 2 diabetes mellitus	0.000125	0.000853	CcSEcCtD
Diflunisal—Syncope—Losartan—type 2 diabetes mellitus	0.000124	0.000853	CcSEcCtD
Diflunisal—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000124	0.000852	CcSEcCtD
Diflunisal—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000123	0.000845	CcSEcCtD
Diflunisal—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000123	0.000845	CcSEcCtD
Diflunisal—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000123	0.000842	CcSEcCtD
Diflunisal—Palpitations—Losartan—type 2 diabetes mellitus	0.000123	0.000841	CcSEcCtD
Diflunisal—Nausea—Glimepiride—type 2 diabetes mellitus	0.000122	0.000838	CcSEcCtD
Diflunisal—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000122	0.000836	CcSEcCtD
Diflunisal—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000122	0.000835	CcSEcCtD
Diflunisal—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000122	0.000835	CcSEcCtD
Diflunisal—Salicylic acid—PTGS2—type 2 diabetes mellitus	0.000122	0.0447	CrCbGaD
Diflunisal—Asthenia—Glyburide—type 2 diabetes mellitus	0.000122	0.000835	CcSEcCtD
Diflunisal—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000122	0.000834	CcSEcCtD
Diflunisal—Anorexia—Metformin—type 2 diabetes mellitus	0.000122	0.000833	CcSEcCtD
Diflunisal—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000121	0.00083	CcSEcCtD
Diflunisal—Fatigue—Valsartan—type 2 diabetes mellitus	0.000121	0.000828	CcSEcCtD
Diflunisal—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000121	0.000826	CcSEcCtD
Diflunisal—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00012	0.000825	CcSEcCtD
Diflunisal—Oedema—Irbesartan—type 2 diabetes mellitus	0.00012	0.000825	CcSEcCtD
Diflunisal—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00012	0.000825	CcSEcCtD
Diflunisal—Pruritus—Glyburide—type 2 diabetes mellitus	0.00012	0.000823	CcSEcCtD
Diflunisal—Constipation—Valsartan—type 2 diabetes mellitus	0.00012	0.000821	CcSEcCtD
Diflunisal—Fatigue—Orlistat—type 2 diabetes mellitus	0.000119	0.000818	CcSEcCtD
Diflunisal—Shock—Irbesartan—type 2 diabetes mellitus	0.000118	0.000812	CcSEcCtD
Diflunisal—Chest pain—Losartan—type 2 diabetes mellitus	0.000118	0.00081	CcSEcCtD
Diflunisal—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000118	0.000809	CcSEcCtD
Diflunisal—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000118	0.000808	CcSEcCtD
Diflunisal—Rash—Bromocriptine—type 2 diabetes mellitus	0.000117	0.000803	CcSEcCtD
Diflunisal—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000117	0.000802	CcSEcCtD
Diflunisal—Tension—Ramipril—type 2 diabetes mellitus	0.000117	0.0008	CcSEcCtD
Diflunisal—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000116	0.000798	CcSEcCtD
Diflunisal—Headache—Bromocriptine—type 2 diabetes mellitus	0.000116	0.000797	CcSEcCtD
Diflunisal—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000116	0.000796	CcSEcCtD
Diflunisal—Nervousness—Ramipril—type 2 diabetes mellitus	0.000116	0.000792	CcSEcCtD
Diflunisal—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000115	0.000786	CcSEcCtD
Diflunisal—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000115	0.000785	CcSEcCtD
Diflunisal—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000115	0.000785	CcSEcCtD
Diflunisal—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000114	0.000784	CcSEcCtD
Diflunisal—Confusional state—Losartan—type 2 diabetes mellitus	0.000114	0.000783	CcSEcCtD
Diflunisal—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000114	0.000782	CcSEcCtD
Diflunisal—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000114	0.000779	CcSEcCtD
Diflunisal—Somnolence—Metformin—type 2 diabetes mellitus	0.000113	0.000777	CcSEcCtD
Diflunisal—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000113	0.000776	CcSEcCtD
Diflunisal—Oedema—Losartan—type 2 diabetes mellitus	0.000113	0.000776	CcSEcCtD
Diflunisal—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000113	0.000776	CcSEcCtD
Diflunisal—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000112	0.00077	CcSEcCtD
Diflunisal—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000112	0.000769	CcSEcCtD
Diflunisal—Shock—Losartan—type 2 diabetes mellitus	0.000111	0.000764	CcSEcCtD
Diflunisal—Urticaria—Valsartan—type 2 diabetes mellitus	0.000111	0.000763	CcSEcCtD
Diflunisal—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000111	0.00076	CcSEcCtD
Diflunisal—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000111	0.00076	CcSEcCtD
Diflunisal—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00011	0.000756	CcSEcCtD
Diflunisal—Fatigue—Metformin—type 2 diabetes mellitus	0.00011	0.000754	CcSEcCtD
Diflunisal—Urticaria—Orlistat—type 2 diabetes mellitus	0.00011	0.000754	CcSEcCtD
Diflunisal—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.00011	0.000751	CcSEcCtD
Diflunisal—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000109	0.00075	CcSEcCtD
Diflunisal—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000109	0.00075	CcSEcCtD
Diflunisal—Constipation—Metformin—type 2 diabetes mellitus	0.000109	0.000748	CcSEcCtD
Diflunisal—Angioedema—Ramipril—type 2 diabetes mellitus	0.000109	0.000745	CcSEcCtD
Diflunisal—Salicylic acid—ALB—type 2 diabetes mellitus	0.000109	0.0399	CrCbGaD
Diflunisal—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000108	0.000741	CcSEcCtD
Diflunisal—Anorexia—Losartan—type 2 diabetes mellitus	0.000108	0.00074	CcSEcCtD
Diflunisal—Vomiting—Glyburide—type 2 diabetes mellitus	0.000108	0.00074	CcSEcCtD
Diflunisal—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000108	0.000739	CcSEcCtD
Diflunisal—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000107	0.000735	CcSEcCtD
Diflunisal—Rash—Glyburide—type 2 diabetes mellitus	0.000107	0.000734	CcSEcCtD
Diflunisal—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000107	0.000733	CcSEcCtD
Diflunisal—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000107	0.000733	CcSEcCtD
Diflunisal—Vertigo—Ramipril—type 2 diabetes mellitus	0.000107	0.000733	CcSEcCtD
Diflunisal—Flurbiprofen—PTGS2—type 2 diabetes mellitus	0.000107	0.0392	CrCbGaD
Diflunisal—Syncope—Ramipril—type 2 diabetes mellitus	0.000107	0.000731	CcSEcCtD
Diflunisal—Headache—Glyburide—type 2 diabetes mellitus	0.000106	0.000729	CcSEcCtD
Diflunisal—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000106	0.000726	CcSEcCtD
Diflunisal—Palpitations—Ramipril—type 2 diabetes mellitus	0.000105	0.000721	CcSEcCtD
Diflunisal—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000105	0.00072	CcSEcCtD
Diflunisal—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000105	0.000717	CcSEcCtD
Diflunisal—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000105	0.000717	CcSEcCtD
Diflunisal—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000104	0.000715	CcSEcCtD
Diflunisal—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000104	0.000715	CcSEcCtD
Diflunisal—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000104	0.000711	CcSEcCtD
Diflunisal—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000103	0.000707	CcSEcCtD
Diflunisal—Constipation—Irbesartan—type 2 diabetes mellitus	0.000103	0.000705	CcSEcCtD
Diflunisal—Insomnia—Losartan—type 2 diabetes mellitus	0.000102	0.000702	CcSEcCtD
Diflunisal—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000102	0.000699	CcSEcCtD
Diflunisal—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000102	0.000697	CcSEcCtD
Diflunisal—Urticaria—Metformin—type 2 diabetes mellitus	0.000101	0.000694	CcSEcCtD
Diflunisal—Chest pain—Ramipril—type 2 diabetes mellitus	0.000101	0.000694	CcSEcCtD
Diflunisal—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000101	0.000692	CcSEcCtD
Diflunisal—Nausea—Glyburide—type 2 diabetes mellitus	0.000101	0.000691	CcSEcCtD
Diflunisal—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000101	0.000691	CcSEcCtD
Diflunisal—Somnolence—Losartan—type 2 diabetes mellitus	0.000101	0.00069	CcSEcCtD
Diflunisal—Asthenia—Valsartan—type 2 diabetes mellitus	0.0001	0.000689	CcSEcCtD
Diflunisal—Dyspepsia—Losartan—type 2 diabetes mellitus	9.97e-05	0.000683	CcSEcCtD
Diflunisal—Asthenia—Orlistat—type 2 diabetes mellitus	9.93e-05	0.000681	CcSEcCtD
Diflunisal—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	9.92e-05	0.00068	CcSEcCtD
Diflunisal—Pruritus—Valsartan—type 2 diabetes mellitus	9.91e-05	0.000679	CcSEcCtD
Diflunisal—Decreased appetite—Losartan—type 2 diabetes mellitus	9.85e-05	0.000675	CcSEcCtD
Diflunisal—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	9.84e-05	0.000675	CcSEcCtD
Diflunisal—Confusional state—Ramipril—type 2 diabetes mellitus	9.79e-05	0.000671	CcSEcCtD
Diflunisal—Pruritus—Orlistat—type 2 diabetes mellitus	9.79e-05	0.000671	CcSEcCtD
Diflunisal—Fatigue—Losartan—type 2 diabetes mellitus	9.77e-05	0.000669	CcSEcCtD
Diflunisal—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	9.71e-05	0.000666	CcSEcCtD
Diflunisal—Oedema—Ramipril—type 2 diabetes mellitus	9.71e-05	0.000666	CcSEcCtD
Diflunisal—Vomiting—Gliclazide—type 2 diabetes mellitus	9.69e-05	0.000664	CcSEcCtD
Diflunisal—Constipation—Losartan—type 2 diabetes mellitus	9.69e-05	0.000664	CcSEcCtD
Diflunisal—Rash—Gliclazide—type 2 diabetes mellitus	9.61e-05	0.000659	CcSEcCtD
Diflunisal—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.6e-05	0.000658	CcSEcCtD
Diflunisal—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.58e-05	0.000657	CcSEcCtD
Diflunisal—Urticaria—Irbesartan—type 2 diabetes mellitus	9.56e-05	0.000655	CcSEcCtD
Diflunisal—Shock—Ramipril—type 2 diabetes mellitus	9.56e-05	0.000655	CcSEcCtD
Diflunisal—Headache—Gliclazide—type 2 diabetes mellitus	9.55e-05	0.000655	CcSEcCtD
Diflunisal—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.51e-05	0.000652	CcSEcCtD
Diflunisal—Flurbiprofen—ALB—type 2 diabetes mellitus	9.51e-05	0.0349	CrCbGaD
Diflunisal—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	9.51e-05	0.000652	CcSEcCtD
Diflunisal—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.47e-05	0.000649	CcSEcCtD
Diflunisal—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.39e-05	0.000644	CcSEcCtD
Diflunisal—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.33e-05	0.00064	CcSEcCtD
Diflunisal—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.26e-05	0.000635	CcSEcCtD
Diflunisal—Dizziness—Valsartan—type 2 diabetes mellitus	9.26e-05	0.000635	CcSEcCtD
Diflunisal—Anorexia—Ramipril—type 2 diabetes mellitus	9.26e-05	0.000635	CcSEcCtD
Diflunisal—Dizziness—Orlistat—type 2 diabetes mellitus	9.15e-05	0.000627	CcSEcCtD
Diflunisal—Asthenia—Metformin—type 2 diabetes mellitus	9.15e-05	0.000627	CcSEcCtD
Diflunisal—Nausea—Gliclazide—type 2 diabetes mellitus	9.05e-05	0.000621	CcSEcCtD
Diflunisal—Pruritus—Metformin—type 2 diabetes mellitus	9.02e-05	0.000618	CcSEcCtD
Diflunisal—Urticaria—Losartan—type 2 diabetes mellitus	9e-05	0.000617	CcSEcCtD
Diflunisal—Body temperature increased—Losartan—type 2 diabetes mellitus	8.95e-05	0.000614	CcSEcCtD
Diflunisal—Vomiting—Valsartan—type 2 diabetes mellitus	8.9e-05	0.00061	CcSEcCtD
Diflunisal—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	8.87e-05	0.000608	CcSEcCtD
Diflunisal—Rash—Valsartan—type 2 diabetes mellitus	8.83e-05	0.000605	CcSEcCtD
Diflunisal—Dermatitis—Valsartan—type 2 diabetes mellitus	8.82e-05	0.000605	CcSEcCtD
Diflunisal—Vomiting—Orlistat—type 2 diabetes mellitus	8.8e-05	0.000603	CcSEcCtD
Diflunisal—Insomnia—Ramipril—type 2 diabetes mellitus	8.78e-05	0.000602	CcSEcCtD
Diflunisal—Headache—Valsartan—type 2 diabetes mellitus	8.77e-05	0.000601	CcSEcCtD
Diflunisal—Diarrhoea—Metformin—type 2 diabetes mellitus	8.73e-05	0.000598	CcSEcCtD
Diflunisal—Rash—Orlistat—type 2 diabetes mellitus	8.73e-05	0.000598	CcSEcCtD
Diflunisal—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.72e-05	0.000598	CcSEcCtD
Diflunisal—Dermatitis—Orlistat—type 2 diabetes mellitus	8.72e-05	0.000598	CcSEcCtD
Diflunisal—Headache—Orlistat—type 2 diabetes mellitus	8.67e-05	0.000594	CcSEcCtD
Diflunisal—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.66e-05	0.000593	CcSEcCtD
Diflunisal—Asthenia—Irbesartan—type 2 diabetes mellitus	8.64e-05	0.000592	CcSEcCtD
Diflunisal—Somnolence—Ramipril—type 2 diabetes mellitus	8.63e-05	0.000592	CcSEcCtD
Diflunisal—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.55e-05	0.000586	CcSEcCtD
Diflunisal—Pruritus—Irbesartan—type 2 diabetes mellitus	8.52e-05	0.000584	CcSEcCtD
Diflunisal—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.44e-05	0.000579	CcSEcCtD
Diflunisal—Dizziness—Metformin—type 2 diabetes mellitus	8.43e-05	0.000578	CcSEcCtD
Diflunisal—Fatigue—Ramipril—type 2 diabetes mellitus	8.37e-05	0.000574	CcSEcCtD
Diflunisal—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.35e-05	0.000572	CcSEcCtD
Diflunisal—Nausea—Valsartan—type 2 diabetes mellitus	8.32e-05	0.00057	CcSEcCtD
Diflunisal—Constipation—Ramipril—type 2 diabetes mellitus	8.31e-05	0.000569	CcSEcCtD
Diflunisal—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.24e-05	0.000564	CcSEcCtD
Diflunisal—Nausea—Orlistat—type 2 diabetes mellitus	8.22e-05	0.000563	CcSEcCtD
Diflunisal—Asthenia—Losartan—type 2 diabetes mellitus	8.13e-05	0.000557	CcSEcCtD
Diflunisal—Vomiting—Metformin—type 2 diabetes mellitus	8.11e-05	0.000556	CcSEcCtD
Diflunisal—Rash—Metformin—type 2 diabetes mellitus	8.04e-05	0.000551	CcSEcCtD
Diflunisal—Dermatitis—Metformin—type 2 diabetes mellitus	8.03e-05	0.000551	CcSEcCtD
Diflunisal—Pruritus—Losartan—type 2 diabetes mellitus	8.01e-05	0.000549	CcSEcCtD
Diflunisal—Feeling abnormal—Ramipril—type 2 diabetes mellitus	8e-05	0.000549	CcSEcCtD
Diflunisal—Headache—Metformin—type 2 diabetes mellitus	7.99e-05	0.000548	CcSEcCtD
Diflunisal—Dizziness—Irbesartan—type 2 diabetes mellitus	7.96e-05	0.000546	CcSEcCtD
Diflunisal—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.94e-05	0.000544	CcSEcCtD
Diflunisal—Diarrhoea—Losartan—type 2 diabetes mellitus	7.75e-05	0.000531	CcSEcCtD
Diflunisal—Urticaria—Ramipril—type 2 diabetes mellitus	7.72e-05	0.000529	CcSEcCtD
Diflunisal—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.68e-05	0.000526	CcSEcCtD
Diflunisal—Vomiting—Irbesartan—type 2 diabetes mellitus	7.65e-05	0.000525	CcSEcCtD
Diflunisal—Rash—Irbesartan—type 2 diabetes mellitus	7.59e-05	0.00052	CcSEcCtD
Diflunisal—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.58e-05	0.00052	CcSEcCtD
Diflunisal—Nausea—Metformin—type 2 diabetes mellitus	7.58e-05	0.000519	CcSEcCtD
Diflunisal—Headache—Irbesartan—type 2 diabetes mellitus	7.54e-05	0.000517	CcSEcCtD
Diflunisal—Dizziness—Losartan—type 2 diabetes mellitus	7.49e-05	0.000513	CcSEcCtD
Diflunisal—Vomiting—Losartan—type 2 diabetes mellitus	7.2e-05	0.000494	CcSEcCtD
Diflunisal—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.16e-05	0.00049	CcSEcCtD
Diflunisal—Nausea—Irbesartan—type 2 diabetes mellitus	7.15e-05	0.00049	CcSEcCtD
Diflunisal—Rash—Losartan—type 2 diabetes mellitus	7.14e-05	0.00049	CcSEcCtD
Diflunisal—Dermatitis—Losartan—type 2 diabetes mellitus	7.14e-05	0.000489	CcSEcCtD
Diflunisal—Headache—Losartan—type 2 diabetes mellitus	7.1e-05	0.000486	CcSEcCtD
Diflunisal—Asthenia—Ramipril—type 2 diabetes mellitus	6.97e-05	0.000478	CcSEcCtD
Diflunisal—Pruritus—Ramipril—type 2 diabetes mellitus	6.87e-05	0.000471	CcSEcCtD
Diflunisal—Nausea—Losartan—type 2 diabetes mellitus	6.73e-05	0.000461	CcSEcCtD
Diflunisal—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.65e-05	0.000455	CcSEcCtD
Diflunisal—Dizziness—Ramipril—type 2 diabetes mellitus	6.42e-05	0.00044	CcSEcCtD
Diflunisal—Vomiting—Ramipril—type 2 diabetes mellitus	6.18e-05	0.000423	CcSEcCtD
Diflunisal—Rash—Ramipril—type 2 diabetes mellitus	6.12e-05	0.00042	CcSEcCtD
Diflunisal—Dermatitis—Ramipril—type 2 diabetes mellitus	6.12e-05	0.000419	CcSEcCtD
Diflunisal—Headache—Ramipril—type 2 diabetes mellitus	6.08e-05	0.000417	CcSEcCtD
Diflunisal—Nausea—Ramipril—type 2 diabetes mellitus	5.77e-05	0.000395	CcSEcCtD
Diflunisal—ALB—Metabolism—NCOA6—type 2 diabetes mellitus	1.13e-05	0.000136	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.12e-05	0.000136	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CETP—type 2 diabetes mellitus	1.12e-05	0.000135	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.12e-05	0.000135	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ALDOB—type 2 diabetes mellitus	1.11e-05	0.000134	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.11e-05	0.000134	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.11e-05	0.000134	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NAMPT—type 2 diabetes mellitus	1.11e-05	0.000134	CbGpPWpGaD
Diflunisal—ALB—Metabolism—UCP2—type 2 diabetes mellitus	1.11e-05	0.000133	CbGpPWpGaD
Diflunisal—ALB—Metabolism—UCP3—type 2 diabetes mellitus	1.11e-05	0.000133	CbGpPWpGaD
Diflunisal—ALB—Metabolism—HSD11B1—type 2 diabetes mellitus	1.11e-05	0.000133	CbGpPWpGaD
Diflunisal—PTGS2—Disease—GCK—type 2 diabetes mellitus	1.1e-05	0.000133	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IAPP—type 2 diabetes mellitus	1.1e-05	0.000132	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.08e-05	0.000131	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SLC9A1—type 2 diabetes mellitus	1.08e-05	0.00013	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.07e-05	0.000129	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.07e-05	0.000129	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—CD36—type 2 diabetes mellitus	1.07e-05	0.000129	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.06e-05	0.000128	CbGpPWpGaD
Diflunisal—TTR—Disease—SRC—type 2 diabetes mellitus	1.06e-05	0.000128	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.06e-05	0.000128	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PPP2CA—type 2 diabetes mellitus	1.06e-05	0.000127	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.06e-05	0.000127	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.06e-05	0.000127	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.05e-05	0.000126	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.05e-05	0.000126	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PSMD6—type 2 diabetes mellitus	1.04e-05	0.000126	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—SREBF1—type 2 diabetes mellitus	1.04e-05	0.000126	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—SNAP25—type 2 diabetes mellitus	1.04e-05	0.000126	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PCK1—type 2 diabetes mellitus	1.04e-05	0.000125	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GLP1R—type 2 diabetes mellitus	1.04e-05	0.000125	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CTGF—type 2 diabetes mellitus	1.02e-05	0.000124	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.02e-05	0.000124	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.02e-05	0.000123	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—HMGCR—type 2 diabetes mellitus	1.02e-05	0.000122	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	1.01e-05	0.000122	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HMGA1—type 2 diabetes mellitus	1.01e-05	0.000122	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.01e-05	0.000122	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.01e-05	0.000122	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1e-05	0.000121	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	9.99e-06	0.00012	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ADRA2A—type 2 diabetes mellitus	9.94e-06	0.00012	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SNAP25—type 2 diabetes mellitus	9.89e-06	0.000119	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PSMD6—type 2 diabetes mellitus	9.89e-06	0.000119	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	9.87e-06	0.000119	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—MMP1—type 2 diabetes mellitus	9.74e-06	0.000118	CbGpPWpGaD
Diflunisal—ALB—Metabolism—HK1—type 2 diabetes mellitus	9.74e-06	0.000117	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	9.73e-06	0.000117	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SLC2A2—type 2 diabetes mellitus	9.68e-06	0.000117	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CYBA—type 2 diabetes mellitus	9.58e-06	0.000116	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP2E1—type 2 diabetes mellitus	9.55e-06	0.000115	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	9.53e-06	0.000115	CbGpPWpGaD
Diflunisal—TTR—Disease—TGFB1—type 2 diabetes mellitus	9.51e-06	0.000115	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RELA—type 2 diabetes mellitus	9.48e-06	0.000114	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—MTR—type 2 diabetes mellitus	9.48e-06	0.000114	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CPT1A—type 2 diabetes mellitus	9.48e-06	0.000114	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	9.46e-06	0.000114	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP1A2—type 2 diabetes mellitus	9.44e-06	0.000114	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—SLC2A1—type 2 diabetes mellitus	9.44e-06	0.000114	CbGpPWpGaD
Diflunisal—ALB—Metabolism—LPA—type 2 diabetes mellitus	9.41e-06	0.000113	CbGpPWpGaD
Diflunisal—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	9.41e-06	0.000113	CbGpPWpGaD
Diflunisal—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	9.41e-06	0.000113	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GCKR—type 2 diabetes mellitus	9.41e-06	0.000113	CbGpPWpGaD
Diflunisal—TTR—Disease—EGFR—type 2 diabetes mellitus	9.33e-06	0.000112	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	9.32e-06	0.000112	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NAMPT—type 2 diabetes mellitus	9.3e-06	0.000112	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CALCA—type 2 diabetes mellitus	9.26e-06	0.000112	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	9.24e-06	0.000111	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—HBA1—type 2 diabetes mellitus	9.24e-06	0.000111	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GCK—type 2 diabetes mellitus	9.24e-06	0.000111	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—LIPC—type 2 diabetes mellitus	9.24e-06	0.000111	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP3A4—type 2 diabetes mellitus	9.21e-06	0.000111	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP11A1—type 2 diabetes mellitus	9.18e-06	0.000111	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	9.16e-06	0.00011	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	9.06e-06	0.000109	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GCG—type 2 diabetes mellitus	9.05e-06	0.000109	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—SLC2A4—type 2 diabetes mellitus	9.05e-06	0.000109	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	9.05e-06	0.000109	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	9.02e-06	0.000109	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SLC9A1—type 2 diabetes mellitus	9.02e-06	0.000109	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SLC2A1—type 2 diabetes mellitus	8.95e-06	0.000108	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CETP—type 2 diabetes mellitus	8.91e-06	0.000107	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	8.89e-06	0.000107	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NOS1—type 2 diabetes mellitus	8.82e-06	0.000106	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	8.79e-06	0.000106	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	8.76e-06	0.000106	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	8.75e-06	0.000106	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TCF7L2—type 2 diabetes mellitus	8.73e-06	0.000105	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	8.6e-06	0.000104	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	8.58e-06	0.000104	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SLC2A4—type 2 diabetes mellitus	8.58e-06	0.000103	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.55e-06	0.000103	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	8.49e-06	0.000102	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	8.39e-06	0.000101	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	8.31e-06	0.0001	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SREBF1—type 2 diabetes mellitus	8.29e-06	9.99e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SNAP25—type 2 diabetes mellitus	8.29e-06	9.99e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PSMD6—type 2 diabetes mellitus	8.29e-06	9.99e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CTGF—type 2 diabetes mellitus	8.13e-06	9.81e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.08e-06	9.75e-05	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	8.07e-06	9.73e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—HMGCR—type 2 diabetes mellitus	8.06e-06	9.72e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8e-06	9.64e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.95e-06	9.59e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ADRA2A—type 2 diabetes mellitus	7.89e-06	9.51e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	7.83e-06	9.44e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GNB3—type 2 diabetes mellitus	7.8e-06	9.41e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.8e-06	9.41e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	7.79e-06	9.4e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	7.79e-06	9.39e-05	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—AKT1—type 2 diabetes mellitus	7.77e-06	9.37e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—HMOX1—type 2 diabetes mellitus	7.76e-06	9.36e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	7.67e-06	9.25e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—MTR—type 2 diabetes mellitus	7.67e-06	9.25e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CAT—type 2 diabetes mellitus	7.66e-06	9.24e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	7.58e-06	9.14e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	7.52e-06	9.07e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	7.49e-06	9.04e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	7.49e-06	9.04e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.48e-06	9.02e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—LIPC—type 2 diabetes mellitus	7.47e-06	9.01e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—HBA1—type 2 diabetes mellitus	7.47e-06	9.01e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GCK—type 2 diabetes mellitus	7.47e-06	9.01e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	7.46e-06	9e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SRC—type 2 diabetes mellitus	7.45e-06	8.99e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—APOB—type 2 diabetes mellitus	7.44e-06	8.97e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	7.43e-06	8.96e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	7.4e-06	8.92e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	7.31e-06	8.81e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	7.29e-06	8.8e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.26e-06	8.75e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTM1—type 2 diabetes mellitus	7.23e-06	8.72e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	7.23e-06	8.72e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CETP—type 2 diabetes mellitus	7.21e-06	8.7e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	7.18e-06	8.66e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	7.18e-06	8.66e-05	CbGpPWpGaD
Diflunisal—TTR—Disease—IL6—type 2 diabetes mellitus	7.17e-06	8.65e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—LPL—type 2 diabetes mellitus	7.1e-06	8.56e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	7.06e-06	8.52e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	7.06e-06	8.52e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—APOB—type 2 diabetes mellitus	7.05e-06	8.5e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ADCY5—type 2 diabetes mellitus	6.95e-06	8.38e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GPX1—type 2 diabetes mellitus	6.93e-06	8.36e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CD36—type 2 diabetes mellitus	6.75e-06	8.14e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—LPL—type 2 diabetes mellitus	6.73e-06	8.12e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	6.7e-06	8.08e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	6.7e-06	8.08e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	6.7e-06	8.08e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.66e-06	8.04e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.66e-06	8.03e-05	CbGpPWpGaD
Diflunisal—TTR—Disease—AKT1—type 2 diabetes mellitus	6.61e-06	7.98e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	6.59e-06	7.95e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CTGF—type 2 diabetes mellitus	6.58e-06	7.94e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.53e-06	7.88e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	6.52e-06	7.86e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.43e-06	7.76e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	6.39e-06	7.71e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	6.38e-06	7.7e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	6.32e-06	7.62e-05	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	6.3e-06	7.6e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	6.27e-06	7.56e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CCR5—type 2 diabetes mellitus	6.2e-06	7.48e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.19e-06	7.47e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	6.19e-06	7.47e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	6.16e-06	7.43e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	6.13e-06	7.39e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	6.08e-06	7.33e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	6.08e-06	7.33e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	6.06e-06	7.31e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	6.06e-06	7.31e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	6.06e-06	7.31e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	5.97e-06	7.2e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	5.95e-06	7.18e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	5.91e-06	7.13e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	5.9e-06	7.12e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	5.88e-06	7.1e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.88e-06	7.09e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GCG—type 2 diabetes mellitus	5.81e-06	7.01e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	5.81e-06	7.01e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	5.78e-06	6.97e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IRS2—type 2 diabetes mellitus	5.77e-06	6.95e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	5.74e-06	6.93e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CALM1—type 2 diabetes mellitus	5.66e-06	6.83e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—APOE—type 2 diabetes mellitus	5.64e-06	6.8e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	5.64e-06	6.8e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—APOA1—type 2 diabetes mellitus	5.58e-06	6.73e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	5.52e-06	6.66e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	5.5e-06	6.63e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	5.36e-06	6.46e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	5.29e-06	6.38e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NOS2—type 2 diabetes mellitus	5.26e-06	6.34e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—SRC—type 2 diabetes mellitus	5.23e-06	6.3e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	5.18e-06	6.25e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	5.09e-06	6.14e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—INS—type 2 diabetes mellitus	5.09e-06	6.13e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	5.08e-06	6.12e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IRS1—type 2 diabetes mellitus	5.03e-06	6.07e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL6—type 2 diabetes mellitus	5.02e-06	6.05e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GNB3—type 2 diabetes mellitus	5.01e-06	6.04e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.01e-06	6.04e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	4.99e-06	6.01e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	4.98e-06	6.01e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CAT—type 2 diabetes mellitus	4.92e-06	5.93e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	4.82e-06	5.82e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—INS—type 2 diabetes mellitus	4.82e-06	5.81e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—APOB—type 2 diabetes mellitus	4.78e-06	5.76e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	4.74e-06	5.72e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	4.73e-06	5.7e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	4.67e-06	5.63e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	4.67e-06	5.63e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	4.66e-06	5.62e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—AKT2—type 2 diabetes mellitus	4.66e-06	5.62e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	4.65e-06	5.6e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.63e-06	5.59e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—LPL—type 2 diabetes mellitus	4.56e-06	5.5e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	4.47e-06	5.38e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.46e-06	5.38e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	4.46e-06	5.38e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GPX1—type 2 diabetes mellitus	4.45e-06	5.37e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	4.43e-06	5.34e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CD36—type 2 diabetes mellitus	4.33e-06	5.23e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	4.28e-06	5.16e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	4.23e-06	5.1e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NOS3—type 2 diabetes mellitus	4.23e-06	5.1e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	4.12e-06	4.96e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	4.11e-06	4.95e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	4.08e-06	4.92e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—INS—type 2 diabetes mellitus	4.04e-06	4.87e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PPARA—type 2 diabetes mellitus	4.03e-06	4.86e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—AGT—type 2 diabetes mellitus	3.9e-06	4.71e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CALM1—type 2 diabetes mellitus	3.84e-06	4.63e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—APOE—type 2 diabetes mellitus	3.82e-06	4.61e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—APOA1—type 2 diabetes mellitus	3.78e-06	4.56e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	3.7e-06	4.46e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	3.54e-06	4.27e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.54e-06	4.27e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PPARG—type 2 diabetes mellitus	3.33e-06	4.02e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—INS—type 2 diabetes mellitus	3.27e-06	3.94e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	3.25e-06	3.92e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SRC—type 2 diabetes mellitus	3.13e-06	3.77e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NOS3—type 2 diabetes mellitus	2.86e-06	3.45e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	2.86e-06	3.45e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	2.8e-06	3.37e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EGFR—type 2 diabetes mellitus	2.74e-06	3.31e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	2.62e-06	3.16e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IL6—type 2 diabetes mellitus	2.11e-06	2.54e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	2.05e-06	2.47e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—AKT1—type 2 diabetes mellitus	1.94e-06	2.34e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	1.63e-06	1.96e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1.32e-06	1.59e-05	CbGpPWpGaD
